| Cash Flow | 2025-09-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Net earnings/(loss) | 454 | 1,326 | 818 | 417 |
| Depreciation and amortization | 233 | 581 | 374 | 182 |
| Impairments and loss on sale of other investments | - | -2 | -2 | - |
| Gain (loss) on sale of investments | 5 | - | - | 1 |
| Impairments and (gain)/loss on disposal of assets, net | -2 | 15 | -2 | 1 |
| Share-based compensation | 93 | 91 | 60 | 30 |
| Provision for bad debts | 13 | 41 | 28 | 16 |
| (increase)/decrease in trade receivables | 539 | 367 | 253 | -288 |
| Increase in inventories | 736 | 1,209 | 1,967 | 678 |
| Increase/(decrease) in accounts payable | 2,147 | 954 | -470 | -1,394 |
| Other accrued liabilities and operating items, net | 699 | 534 | 641 | 508 |
| Net cash provided by/(used in) operating activities | 973 | 870 | -2,047 | -1,647 |
| Payments to acquire businesses, net of cash acquired | 41 | 3,855 | 1,076 | - |
| Proceeds from divestitures, net of cash sold | - | 2 | 2 | 2 |
| Additions to property and equipment | 108 | 315 | 189 | 90 |
| Proceeds from disposal of property and equipment | - | 3 | 0 | 0 |
| Purchases of investments | - | 6 | 3 | - |
| Proceeds from investments | - | 7 | 2 | - |
| Proceeds from net investment hedge terminations | - | 2 | 0 | 0 |
| Payments to acquire restricted certificates of deposit | - | 0 | - | - |
| Proceeds from short-term investment in time deposit | - | 200 | 200 | - |
| Increase (decrease) in other investing items, net | 7 | - | - | - |
| Net cash used in investing activities | -142 | -3,962 | -1,064 | -88 |
| Proceeds from long-term obligations, net of issuance costs | - | 2,869 | 2,869 | - |
| Proceeds from debt, net of issuance costs | 989 | - | - | - |
| Reduction of long-term obligations | 512 | 434 | 423 | 9 |
| Payments to noncontrolling interests | 3 | - | - | - |
| Net tax withholding from share-based compensation | -80 | -12 | -15 | -28 |
| Dividends on common shares | 129 | 374 | 250 | 128 |
| Purchase of treasury shares | 375 | 765 | 390 | 375 |
| Net cash used in financing activities | -110 | 1,284 | 1,791 | -540 |
| Effect of exchange rates changes on cash and equivalents | -2 | 1 | -3 | 9 |
| Net increase/(decrease) in cash and equivalents | 719 | -1,807 | -1,323 | -2,266 |
| Cash and cash equivalents at beginning of period | 3,874 | 5,133 | 5,133 | 5,133 |
| Cash and cash equivalents at end of period | 4,593 | 3,326 | 3,810 | 2,867 |
CARDINAL HEALTH INC (CAH)
CARDINAL HEALTH INC (CAH)